Position in GSK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,104,686
+$5,071,834 QoQ
Shares Held
497,991
+30.7% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#62
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $17,081,497,167 across 17 Drug Manufacturers - General names. GSK ranks #13 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,996,669 | $3,594,294,994 | |
| 2 | JNJ |
Johnson & Johnson
|
13,401,691 | $3,403,627,461 | |
| 3 | ABBV |
AbbVie Inc.
|
11,519,507 | $2,898,768,740 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,387,435 | $2,234,285,396 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,670,064 | $1,536,729,084 | |
| 6 | AZN |
Astrazeneca PLC
|
6,095,430 | $1,155,815,432 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,618,082 | $962,468,477 | |
| 8 | AMGN |
Amgen Inc
|
1,897,321 | $687,057,877 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,104,686 | 497,991 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $21,032,852 | 381,099 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $14,730,781 | 300,383 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $13,263,326 | 307,306 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $15,428,235 | 401,777 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,376,756 | 396,922 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $16,190,984 | 478,740 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $21,705,807 | 530,964 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $23,357,949 | 606,700 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $23,171,147 | 540,498 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $22,833,257 | 616,116 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $46,065,846 | 1,270,782 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $43,731,312 | 1,227,029 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $36,913,431 | 1,037,477 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $31,232,606 | 888,805 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $24,216,739 | 822,859 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $55,080,200 | 1,290,109 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $51,882,614 | 1,214,377 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $39,141,448 | 904,936 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $28,266,774 | 754,256 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $39,239,210 | 1,004,705 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $59,789,585 | 1,708,042 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $78,227,764 | 2,167,368 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $111,648,508 | 3,024,286 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $131,125,910 | 3,277,588 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $127,907,640 | 3,441,846 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||